{
    "title": "ALEX BRUMMER: Pharma giant Astrazeneca's \u00a3100bn plus valuation and \u00a330bn bid for Alexion is a tonic for global Britain",
    "url": "https://www.dailymail.co.uk/money/comment/article-9052461/ALEX-BRUMMER-Astrazeneca-tonic-global-Britain.html",
    "date": "2020-12-14",
    "keywords": [
        "bid",
        "alexion",
        "share",
        "soriot",
        "case",
        "fund",
        "time",
        "executive",
        "pfizer",
        "foot",
        "azs",
        "project",
        "company",
        "ambition",
        "life",
        "product",
        "shot",
        "arm",
        "deal",
        "power",
        "spite",
        "vaccine",
        "treatment",
        "target",
        "firm",
        "government",
        "sector",
        "capital",
        "asset",
        "model",
        "investment",
        "account",
        "fee",
        "az",
        "runup",
        "brexit",
        "referendum",
        "valuation",
        "aia",
        "day",
        "science",
        "innovation",
        "video",
        "maker",
        "hammer",
        "infant",
        "level",
        "problem",
        "country",
        "invention",
        "valley",
        "gold",
        "pharma",
        "glaxo",
        "merger",
        "kline",
        "beecham",
        "hegemony",
        "head",
        "jeanpierre",
        "garnier",
        "value",
        "destruction",
        "technology",
        "brief",
        "top",
        "ftse",
        "ground",
        "immunology",
        "fruition",
        "concern",
        "midst",
        "work",
        "oxfordjenner",
        "covid",
        "approval",
        "transaction",
        "height",
        "pandemic",
        "astra",
        "cash",
        "loan",
        "companys",
        "rd",
        "expertise",
        "blood",
        "research",
        "profit",
        "confidence",
        "relief",
        "management",
        "record",
        "safer",
        "home",
        "distribution",
        "asia",
        "china",
        "astrazeneca",
        "storm",
        "pharmas"
    ],
    "category": [
        "money",
        "comment"
    ]
}